YL-13027 in Patients With Advanced Solid Tumors
Clinical trial NCT05228600 · UNKNOWN
Trial details
- NCT number
- NCT05228600
- Sponsor
- Shanghai YingLi Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2022-12-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.